Free Trial

Acelyrin (SLRN) Insider Trading & Ownership

Acelyrin logo
$5.68
-0.22 (-3.73%)
(As of 10/31/2024 ET)

Acelyrin (NASDAQ:SLRN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$198,554.77
Get SLRN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acelyrin stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SLRN Insider Buying and Selling by Quarter

Acelyrin Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/17/2024Daniel J BeckerDirectorSell1$6.86$6.86  
2/20/2024Shao-Lee LinCEOSell15,701$7.60$119,327.60  
1/2/2024Shao-Lee LinCEOSell10,691$7.41$79,220.31  
(Data available from 1/1/2013 forward)

SLRN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Acelyrin includes Beth C Seidenberg, Biopartners Fund Ii Westlake, Daniel J Becker, Mardi Dier, Ronald Oyston, and Shao-Lee Lin. Learn more on insiders at SLRN.

13.60% of Acelyrin stock is owned by insiders. Learn more on SLRN's insider holdings.

The following insiders have purchased SLRN shares in the last 24 months: Beth C Seidenberg ($1,080,000.00), Biopartners Fund Ii Westlake ($22,500,000.00), Mardi Dier ($100,008.00), and Ronald Oyston ($18,000.00).

Insiders have purchased a total of 1,316,556 SLRN shares in the last 24 months for a total of $23,698,008.00 bought.

The following insiders have sold SLRN shares in the last 24 months: Daniel J Becker ($6.86), and Shao-Lee Lin ($198,547.91).

Insiders have sold a total of 26,393 Acelyrin shares in the last 24 months for a total of $198,554.77 sold.



This page (NASDAQ:SLRN) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners